$XXII
22nd Century Group, Inc.

2014 Q2 Form 10-Q Financial Statement

#000114420414049578 Filed on August 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q4 2013 Q2
Revenue $16.11K $7.230M $0.00
YoY Change
Cost Of Revenue $13.18K $440.0K $0.00
YoY Change 4300.0%
Gross Profit $2.938K $6.780M $0.00
YoY Change
Gross Profit Margin 18.23% 93.78%
Selling, General & Admin $1.379M $650.0K $1.401M
YoY Change -1.55% 32.65% 29.32%
% of Gross Profit 46931.25% 9.59%
Research & Development $263.3K $250.0K $165.1K
YoY Change 59.51% 4.17% -31.57%
% of Gross Profit 8963.07% 3.69%
Depreciation & Amortization $74.68K -$30.00K $60.00K
YoY Change 24.47% -115.0% 20.0%
% of Gross Profit 2541.83% -0.44%
Operating Expenses $2.041M $870.0K $1.566M
YoY Change 30.37% 11.54% 18.23%
Operating Profit -$2.038M $5.910M -$1.623M
YoY Change 25.61% -857.69% 18.07%
Interest Expense $1.769K -$10.12M $1.180M
YoY Change -99.85% 187.5% -22.37%
% of Operating Profit -171.24%
Other Income/Expense, Net $72.35K -$3.610M $1.177M
YoY Change -93.85% -22.38%
Pretax Income -$1.970M -$7.820M -$450.0K
YoY Change 337.78% 81.44% -421.43%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.966M -$7.820M -$446.0K
YoY Change 340.81% 81.86% -414.57%
Net Earnings / Revenue -12199.42% -108.16%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$33.53K -$153.5K -$0.01
COMMON SHARES
Basic Shares Outstanding 58.75M shares 49.72M shares 39.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q4 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.170M $5.830M $450.0K
YoY Change 826.67%
Cash & Equivalents $4.173M $5.831M
Short-Term Investments
Other Short-Term Assets $250.0K $460.0K $30.00K
YoY Change 733.33% 4500.0% -40.0%
Inventory $1.733M $1.406M $1.257M
Prepaid Expenses $251.1K $0.00 $32.85K
Receivables $16.11K $0.00 $40.00K
Other Receivables $0.00 $10.00K $10.00K
Total Short-Term Assets $6.218M $7.744M $1.789M
YoY Change 247.63% 504.39% 41.95%
LONG-TERM ASSETS
Property, Plant & Equipment $2.950M $2.998M $27.80K
YoY Change 10509.98% 49614.1% 178.04%
Goodwill $0.00
YoY Change
Intangibles $1.545M $1.345M
YoY Change 14.16%
Long-Term Investments $250.0K $7.529M
YoY Change
Other Assets $1.545M $0.00
YoY Change -100.0%
Total Long-Term Assets $2.071M $1.545M $1.373M
YoY Change 50.84% 13.8% -3.99%
TOTAL ASSETS
Total Short-Term Assets $6.218M $7.744M $1.789M
Total Long-Term Assets $2.071M $1.545M $1.373M
Total Assets $11.24M $12.29M $3.161M
YoY Change 255.53% 364.55% 17.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $730.0K $54.67K $422.5K
YoY Change 72.76% -96.12% -62.27%
Accrued Expenses $660.0K $575.7K $329.9K
YoY Change 100.09% 14.46% -25.03%
Deferred Revenue
YoY Change
Short-Term Debt $170.0K $170.0K $370.0K
YoY Change -54.05% -91.79% -73.94%
Long-Term Debt Due $0.00 $1.050M
YoY Change -100.0% 118.75%
Total Short-Term Liabilities $1.562M $984.3K $2.279M
YoY Change -31.48% -78.62% -34.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $180.0K
YoY Change -100.0% 28.57%
Other Long-Term Liabilities $550.0K $3.780M $7.920M
YoY Change -93.06% -9.35% 620.0%
Total Long-Term Liabilities $550.0K $3.780M $8.100M
YoY Change -93.21% -9.35% 553.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.562M $984.3K $2.279M
Total Long-Term Liabilities $550.0K $3.780M $8.100M
Total Liabilities $2.111M $4.764M $10.37M
YoY Change -79.65% -45.72% 121.14%
SHAREHOLDERS EQUITY
Retained Earnings -$47.21M -$39.93M -$16.74M
YoY Change 182.1% 189.84%
Common Stock $593.00 $569.00 $444.00
YoY Change 33.56% 65.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.130M $7.523M -$7.210M
YoY Change
Total Liabilities & Shareholders Equity $11.24M $12.29M $3.161M
YoY Change 255.55% 364.55% 17.53%

Cashflow Statement

Concept 2014 Q2 2013 Q4 2013 Q2
OPERATING ACTIVITIES
Net Income -$1.966M -$7.820M -$446.0K
YoY Change 340.81% 81.86% -414.57%
Depreciation, Depletion And Amortization $74.68K -$30.00K $60.00K
YoY Change 24.47% -115.0% 20.0%
Cash From Operating Activities -$1.110M $6.280M -$370.0K
YoY Change 200.0% -1465.22% -50.67%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K -$680.0K $0.00
YoY Change 325.0%
Acquisitions
YoY Change
Other Investing Activities -$330.0K -$2.970M $0.00
YoY Change
Cash From Investing Activities -$390.0K -$3.650M $0.00
YoY Change 2181.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K 2.170M 550.0K
YoY Change -45.45% 250.0% -27.63%
NET CHANGE
Cash From Operating Activities -1.110M 6.280M -370.0K
Cash From Investing Activities -390.0K -3.650M 0.000
Cash From Financing Activities 300.0K 2.170M 550.0K
Net Change In Cash -1.200M 4.800M 180.0K
YoY Change -766.67% 1700.0%
FREE CASH FLOW
Cash From Operating Activities -$1.110M $6.280M -$370.0K
Capital Expenditures -$50.00K -$680.0K $0.00
Free Cash Flow -$1.060M $6.960M -$370.0K
YoY Change 186.49% -2420.0% -50.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
1732977 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
593 USD
CY2013Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
0 USD
CY2013Q4 us-gaap Cash
Cash
5830599 USD
CY2013Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
42069 USD
CY2013Q4 us-gaap Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
7471 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
1406280 USD
CY2014Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2013Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
457696 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2997760 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1544869 USD
CY2014Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2070837 USD
CY2014Q2 us-gaap Cash
Cash
4172795 USD
CY2014Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
44569 USD
CY2014Q2 us-gaap Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
0 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
6217550 USD
CY2013Q2 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1544869 USD
CY2013Q4 us-gaap Assets
Assets
12286744 USD
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
251095 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
7744115 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
569 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
575730 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2013Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
174925 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
179014 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54665 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1561507 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
984334 USD
CY2014Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
549308 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3779522 USD
CY2014Q2 us-gaap Liabilities
Liabilities
2110815 USD
CY2013Q4 us-gaap Liabilities
Liabilities
4763856 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 36.3pt; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt"> Reclassifications</font></i></strong><i><font style="FONT-SIZE: 10pt">-</font></i> <font style="FONT-SIZE: 10pt"> Certain items in the 2013 financial statements have been reclassified to conform to the 2014 classification.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong><i><font style="FONT-SIZE: 10pt"></font></i><strong><font style="FONT-SIZE: 10pt">-</font></strong> <font style="FONT-SIZE: 10pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S., requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56339895 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47452055 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47210679 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39929736 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9129809 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7522888 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11240624 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12286744 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81639 USD
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59325132 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56902770 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59325132 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56902770 shares
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
204000 USD
us-gaap Licenses Revenue
LicensesRevenue
7000000 USD
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
179014 USD
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
7000000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2862564 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2559412 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1134621 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1014543 USD
CY2014Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1727943 USD
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1544869 USD
xxii Working Capital
WorkingCapital
4656043 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4172795 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
2035000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
432767 USD
us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
0 USD
us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
463649 USD
CY2014Q2 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
16114 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
190872 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
13176 USD
us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Gross Profit
GrossProfit
272777 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
2938 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
355835 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
485715 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165087 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
263335 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2548647 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2349867 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1400515 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1344680 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2013Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2014Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
274582 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
109600 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
195613 USD
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
56976 USD
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
124344 USD
us-gaap Costs And Expenses
CostsAndExpenses
3014082 USD
us-gaap Costs And Expenses
CostsAndExpenses
3498122 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
1622578 USD
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
2041101 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3014082 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3225345 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1622578 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2038163 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
242327 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-3993153 USD
CY2013Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1258502 USD
CY2014Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
74117 USD
xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
0 USD
xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
144548 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
85621 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
12156 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
CY2013Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
5610 USD
CY2014Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
us-gaap Interest Expense Other
InterestExpenseOther
175247 USD
us-gaap Interest Expense Other
InterestExpenseOther
3518 USD
CY2013Q2 us-gaap Interest Expense Other
InterestExpenseOther
76269 USD
CY2014Q2 us-gaap Interest Expense Other
InterestExpenseOther
1769 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
54924 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4055598 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1176623 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
72348 USD
us-gaap Profit Loss
ProfitLoss
-2959158 USD
us-gaap Profit Loss
ProfitLoss
-7280943 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-445955 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-1965815 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38059566 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39794189 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58749240 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58075029 shares
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3220000 USD
CY2014Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
210000 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
631484 USD
CY2014Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2997140 USD
CY2014Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
22236 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
17059 USD
CY2014Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
14500 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
14500 USD
CY2014Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
210000 USD
CY2014Q2 xxii Property Plant And Equipment Including Assets Held For Sale
PropertyPlantAndEquipmentIncludingAssetsHeldForSale
3033876 USD
CY2013Q4 xxii Property Plant And Equipment Including Assets Held For Sale
PropertyPlantAndEquipmentIncludingAssetsHeldForSale
3461559 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3033876 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3003863 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6103 USD
CY2013 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075 pure
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075 pure
CY2014Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0400 pure
CY2013Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0400 pure
CY2013Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
19616308 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10653469 shares
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3987655 USD
xxii Percentage Of Warrants Held
PercentageOfWarrantsHeld
0.395 pure
xxii Warrants Without Provision Of Anti Dilution
WarrantsWithoutProvisionOfAntiDilution
9310975 shares
CY2014Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
9440784 USD
CY2013Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
6022319 USD
CY2013Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
711675 USD
CY2013Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1622069 USD
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4173140 USD
xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
-204513 USD
CY2013 xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
-7712170 USD
xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
-6542904 USD
CY2013 xxii Reclassification Of Warrant Liability To Equity Resulting From Warrant Exchange Program
ReclassificationOfWarrantLiabilityToEquityResultingFromWarrantExchangeProgram
-19639465 USD
CY2013 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
3274313 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12972664 shares
CY2013Q4 xxii Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
11570274 shares
CY2013 xxii Class Of Warrants Or Rights Issued Under Warrant Exchange Program
ClassOfWarrantsOrRightsIssuedUnderWarrantExchangeProgram
138666 shares
CY2013 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
1665400 shares
xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
18383 shares
CY2013 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
-9831414 shares
CY2013 xxii Number Of Warrants Exercised Under Warrant Exchange Program
NumberOfWarrantsExercisedUnderWarrantExchangeProgram
5862121 shares
xxii Number Of Warrants Exercised Under Warrant Exchange Program
NumberOfWarrantsExercisedUnderWarrantExchangeProgram
1231068 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9440784 shares
xxii Warrants With Provision Of Anti Dilution
WarrantsWithProvisionOfAntiDilution
129809 shares
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
1000000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
200000 USD
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
800000 USD
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
96000 USD
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
123000 USD
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
298275 USD
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
338250 USD
CY2014Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
338250 USD
xxii Research And Development Arrangement Contract Terms
ResearchAndDevelopmentArrangementContractTerms
two-year term
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
16000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
10000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7280943 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-445955 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965815 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Net Income Loss
NetIncomeLoss
-2959158 USD
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38059566 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58075029 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39794189 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58749240 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26019860 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10600784 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
934400 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1024451 shares
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1949000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
186595 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
103250 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34500 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000 shares
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0189 pure
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0180 pure
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
465000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
215000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
300000 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
910000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
660000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.69
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.80
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.61
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.26
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.69
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.36
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y2M12D
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1555400 USD
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1441150 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
994048 USD
xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
466201 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34500 USD
xxii Other Contributed Capital
OtherContributedCapital
25200 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
7367915 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4232 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
110063 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
17386 USD
xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
912480 USD
us-gaap Share Based Compensation
ShareBasedCompensation
994049 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1024451 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26533 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
288841 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
22802 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
251095 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-312858 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
433339 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
6172 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
69054 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
542229 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
466201 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-127770 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
108396 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-179014 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1507064 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2232530 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14620 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
89352 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
14398 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
130184 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
342894 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-29018 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
395286 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
339250 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2034664 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2500 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2500 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3893 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7471 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1987624 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
505672 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
451542 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1657804 USD
CY2012Q4 us-gaap Cash
Cash
188 USD
CY2013Q2 us-gaap Cash
Cash
451730 USD
us-gaap Interest Paid Net
InterestPaidNet
32339 USD
us-gaap Interest Paid Net
InterestPaidNet
3537 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
204513 USD
xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
7367915 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
85426 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
213800 USD
xxii Machinery And Equipment Included In Accounts Payable
MachineryAndEquipmentIncludedInAccountsPayable
8707 USD
xxii Machinery And Equipment Included In Accounts Payable
MachineryAndEquipmentIncludedInAccountsPayable
25852 USD
xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
0 USD
xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
37856 USD
xxii Other Contributed Capital
OtherContributedCapital
0 USD
xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
769377 USD
xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
0 USD
xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
26422 USD
xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
0 USD
xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
1427705 USD
xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
0 USD
xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
93361 USD
xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
0 USD
xxii Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
416666 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001347858
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
xxii Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
0 USD
xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
57500 USD
xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
0 USD
xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
4174044 USD
xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
0 USD
dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
dei Trading Symbol
TradingSymbol
XXII
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59601688 shares
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16114 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34160 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 USD
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34160 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16114 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1660 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2013Q1 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
2500000 USD
us-gaap Liquidity Disclosure Sufficient Cash And Waivers Note
LiquidityDisclosureSufficientCashAndWaiversNote
The Company believes it will have adequate cash reserves to sustain operations and meet all current obligations as they come due for a period of approximately 8 months.
us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
30 days
CY2014Q2 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
45000000 USD
CY2014Q2 us-gaap Description Of Regulatory Requirements Capital Adequacy Purposes
DescriptionOfRegulatoryRequirementsCapitalAdequacyPurposes
The universal shelf registration statement will allow, but not compel, the Company to raise up to $45 million of capital over a three-year period through a wide array of securities and at increments to be determined by the Company.
CY2013Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
3921381 USD
CY2014Q2 us-gaap Equity Method Investments
EquityMethodInvestments
250000 USD
CY2013Q4 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
457696 USD
CY2014Q4 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
88167 USD
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
4229982 USD
CY2014Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.1 pure
CY2013 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
19271977 USD
CY2014Q2 us-gaap Depreciation
Depreciation
73695 USD

Files In Submission

Name View Source Status
0001144204-14-049578-index-headers.html Edgar Link pending
0001144204-14-049578-index.html Edgar Link pending
0001144204-14-049578.txt Edgar Link pending
0001144204-14-049578-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v384292_10q.htm Edgar Link pending
v384292_ex31-1.htm Edgar Link pending
v384292_ex31-2.htm Edgar Link pending
v384292_ex32-1.htm Edgar Link pending
xxii-20140630.xml Edgar Link completed
xxii-20140630.xsd Edgar Link pending
xxii-20140630_cal.xml Edgar Link unprocessable
xxii-20140630_def.xml Edgar Link unprocessable
xxii-20140630_lab.xml Edgar Link unprocessable
xxii-20140630_pre.xml Edgar Link unprocessable